MEDS 7.59 TRxADE HEALTH, Inc.
| Range: | 3.69-44.56 | Vol Avg: | 61782 | Last Div: | 9.5 | Changes: | 0.33 |
| Beta: | 2.17 | Cap: | 0.01B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Thu Feb 06 2014 | Empoloyees: | 8 | ||
| CUSIP: | 89846A207 | CIK: | 0001382574 | ISIN: | US89846A4058 | Country: | US |
| CEO: | Mr. Surendra K. Ajjarapu | Website: | https://www.trxadehealth.com | ||||
TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Land O' Lakes, Florida.
Stock Details
Neutral 0.00
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc.
TAMPA, FL and COMMACK, NY, Sept. 20, 2024 (GLOBE NEWSWIRE) -- TRxADE Health, Inc. (“TRxADE...
globenewswire.com·Fri Sep 20 2024
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow